CopiOs Posterolateral Fusion Procedure

May 11, 2015 updated by: Zimmer Biomet

A Prospective Study Assessing Clinical Outcomes and Radiographic Results After the Use of CopiOs(R) Bone Void Filler (BVF)Sponge in a Posterolateral Fusion Procedure (PLF).

To compare radiographic data collection from patients undergoing instrumented PLF with CopiOs(R) BVF or instrumented PLF with autologous bone and to assess overall clinical outcomes. Patients will serve as self controls.

Study Overview

Status

Terminated

Intervention / Treatment

Detailed Description

This is a prospective, counter-balanced study involving 85 subjects at up to 8 investigative centers. Each subject will be an appropriate candidate for an instrumented PLF and will meet the inclusion and exclusion criteria. All subjects will undergo an instrumented, pedicle screw PLF procedure. Autograft or other interbody devices identified by the surgeon to be in the best interest of the patient may be used. Enrolled patients will receive CopiOs BVF sponge soaked with bone marrow aspirate on one side and autologous bone on the other side. All patients will receive both CopiOs BVF and autologous bone. Patients will serve as self-controls in this counter-balanced study. Data will be collected pre-operatively, operatively and post-operatively at six and twelve months.

The study objectives include: Radiographic success of CopiOs is non-inferior to autograft with clear evidence of bridging bone. Radiographic analysis will be used to show that CopiOs works as well as autograft when comparing the rate of fusion at 6 and 12 months. The CT scan (12 month) will show that CopiOs works as well as autograft when comparing the fusion mass between the transverse processes. Additionally, clinical success will be determined by an improvement of 15 percentage points using the Oswestry Disability Index and maintenance or improvement in the motor and sensory components of the neurological assessment from preoperative to postoperative. Since patients serve as self-controls there will be no clinical success comparisons between the groups. Rather, clinical success will be measured on overall improvement based on patient outcomes.

Study Type

Interventional

Enrollment (Actual)

45

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Orlando, Florida, United States, 32803
        • Florida Hospital
    • Illinois
      • Belleville, Illinois, United States, 62226
        • Neurological Surgery of Southern Illinois
    • Indiana
      • Indianapolis, Indiana, United States, 46250
        • Indiana Orthopedic Center
    • New Mexico
      • Las Cruces, New Mexico, United States, 88005
        • Las Cruces Orthopaedic Associates
    • New York
      • East Syracuse, New York, United States, 13057
        • Upstate Bone and Joint Center
    • Texas
      • Temple, Texas, United States, 76508
        • Scott and White Healthcare

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years to 81 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patient must be skeletally mature; between the ages of 21 and 75
  • Patients having degenerative spondylolisthesis, stenosis with instability, or degenerative disc disease as diagnosed by radicular signs and/or imaging studies
  • Patients will be medically indicated for a single-level, instrumented PLF between L2 and S1 per their surgeon
  • Patient must be willing and able to comply with study requirements, including all necessary study related paperwork and follow-up visits

Exclusion Criteria:

  • Use of iliac crest bone graft;
  • Any previous lumbar spinal surgeries at indicated level;
  • Any medical or physical condition that would preclude the potential benefit of spinal surgery;
  • Use of a dynamic stabilization systems;
  • Sites where stresses on void will exceed the load strength of fixation of hardware;
  • Segmental defects;
  • Significantly impaired vascularity proximal to the surgical site;
  • Sites in direct contact with articular space;
  • Soft tissue deficit not allowing closure;
  • Active systemic or local infection;
  • Severe degenerative bone disease;
  • Patients with osteoporosis who are actively under treatment;
  • Extreme obesity, as defined by NIH Clinical Guidelines Body Mass Index (BMI>40 kg/m2);
  • Active malignancy;
  • Patients with a history of multiple allergies;
  • Patients with known allergies to bovine collagen;
  • Hypercalcemia;
  • Pregnancy;
  • Mental illness;
  • Alcohol or drug abuse;
  • Incarceration.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Single ARM - Copios Bone Filler
All subjects will undergo an instrumented, pedicle screw PLF procedure. Autograft or other interbody devices identified by the surgeon to be in the best interest of the patient may be used. Enrolled patients will receive CopiOs BVF sponge soaked with bone marrow aspirate on one side and autologous bone on the other side. All patients will receive both CopiOs BVF and autologous bone. Patients will serve as self-controls in this counter-balanced study.
Bone Void Filler

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fusion Assessment
Time Frame: 6 M, 12 M
Fusion at 12M using radiograph Fusion Mass at 12M using CT
6 M, 12 M

Secondary Outcome Measures

Outcome Measure
Time Frame
Outcome Measure - Pain, Life Quality, Satisfaction
Time Frame: PreOp, Surgery, 6M, 12M
PreOp, Surgery, 6M, 12M

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2010

Primary Completion (Actual)

October 1, 2012

Study Completion (Actual)

October 1, 2012

Study Registration Dates

First Submitted

May 12, 2010

First Submitted That Met QC Criteria

May 13, 2010

First Posted (Estimate)

May 14, 2010

Study Record Updates

Last Update Posted (Estimate)

May 27, 2015

Last Update Submitted That Met QC Criteria

May 11, 2015

Last Verified

May 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spondylolisthesis

Clinical Trials on Copios

Subscribe